APA

Asagi A., Ohta K., Nasu J., Tanada M., Nadano S., Nishimura R., Teramoto N., Yamamoto K., Inoue T. & Iguchi H. (20130529). Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence. : Pancreas.

Chicago

Asagi Akinori, Ohta Koji, Nasu Junichirou, Tanada Minoru, Nadano Seijin, Nishimura Rieko, Teramoto Norihiro, Yamamoto Kazuhide, Inoue Takeshi and Iguchi Haruo. 20130529. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence. : Pancreas.

Harvard

Asagi A., Ohta K., Nasu J., Tanada M., Nadano S., Nishimura R., Teramoto N., Yamamoto K., Inoue T. and Iguchi H. (20130529). Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence. : Pancreas.

MLA

Asagi Akinori, Ohta Koji, Nasu Junichirou, Tanada Minoru, Nadano Seijin, Nishimura Rieko, Teramoto Norihiro, Yamamoto Kazuhide, Inoue Takeshi and Iguchi Haruo. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence. : Pancreas. 20130529.